PTX 7.14% 3.9¢ prescient therapeutics limited

Ann: December 2023 Quarterly Update and Appendix 4C, page-2

  1. 94 Posts.
    lightbulb Created with Sketch. 27
    In addition to robust efficacy, PTX-100’s safety profile was acknowledged as a distinguishing feature, which could also make it a viable option for exploring future combination therapies.

    PLUS at least 6 quarters of runway in cash. One for the patient investor who recognises the enormous potential.
 
watchlist Created with Sketch. Add PTX (ASX) to my watchlist
(20min delay)
Last
3.9¢
Change
-0.003(7.14%)
Mkt cap ! $31.40M
Open High Low Value Volume
4.0¢ 4.1¢ 3.9¢ $75.11K 1.897M

Buyers (Bids)

No. Vol. Price($)
2 355874 3.9¢
 

Sellers (Offers)

Price($) Vol. No.
4.0¢ 75 1
View Market Depth
Last trade - 15.59pm 19/06/2024 (20 minute delay) ?
PTX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.